Project Grant HT94252510423
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$932K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This Project Grant award of $498,828.00 from the Defense Health Agency supports the development of a novel treatment strategy and unique methods of delivery to the central nervous system for amyotrophic lateral sclerosis (ALS). The award, effective from July 1, 2023 to June 30, 2025, is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for Service Members and the public through innovative and impactful biomedical...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
This federal Project Grant award, valued at $1,078,882.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research project conducted by the Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, CA. The project aims to investigate a "chemical engineering approach to ALS that amplifies a more sophisticated view of the multimodal therapeutic actions of donor and host neural stem cells in that...
The University of Massachusetts Medical School has been awarded a $987,615 federal Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 30, 2024 to September 29, 2026, supports the "Development of Chimeric Antigen Receptor T Regulatory Cells (CAR Tregs) for the Treatment of Amyotrophic Lateral Sclerosis." This project aims to advance research into new therapeutic approaches for...
This $1,181,251 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research to develop neuronal exosome-based biomarkers for amyotrophic lateral sclerosis (ALS) diagnosis and disease progression. The prime awardee is the University of California, Los Angeles (UCLA), which will leverage its extensive medical research facilities, faculty expertise, and administrative capabilities to conduct this...
This $1,206,372 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program is funding research at the University of Michigan to study the role of primary cilia alterations in the pathogenesis and treatment of systemic sclerosis. The award, which began on April 15, 2025 and runs through April 14, 2029, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
The Department of Defense's Defense Health Agency awarded a $1,500,000 Project Grant to the Regents of the University of Michigan to develop "Regenerative Peripheral Nerve Interfaces to Enhance Function and Sensation in People with Transfemoral Amputation" over 4 years, from September 1, 2023 to August 31, 2027. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members...
This Project Grant award of $2,163,115.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by Pathmaker Neurosystems Inc. to develop a noninvasive neuromodulation approach to slow the progression of amyotrophic lateral sclerosis (ALS) by suppressing neuronal hyperexcitability. The research, taking place in Boston, MA, aims to explore this innovative therapeutic method over the 2-year performance period...